The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.
Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
Labcorp Holdings Inc. (LH), headquartered in Burlington, North Carolina, stands as a premier global life sciences company ...